Boston Scientific Revenue 2024. Health regulator has approved its heart device. Bsx) generated net sales of $3.389 billion during the first quarter of 2023, growing 12.0 percent on a reported basis, 14.9 percent on an operational 1 basis and 14.0 percent on an organic 2 basis, all compared to the prior year period.
Bsx) generated net sales of $3.725 billion during the fourth quarter of 2023, growing 14.9 percent on a. The medical equipment provider reported $0.55 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.04.
Boston Scientific Annual Revenue For 2021 Was $11.888B, A 19.92% Increase From 2020.
Bsx) generated net sales of $3.389 billion during the first quarter of 2023, growing 12.0 percent on a reported basis, 14.9 percent on an operational 1 basis and 14.0 percent on an organic 2 basis, all compared to the prior year period.
The Medical Equipment Provider Reported $0.55 Earnings Per Share For The Quarter, Topping The Consensus Estimate Of $0.51 By $0.04.
Boston scientific annual revenue for 2023 was $14.24b, a 12.29% increase from 2022.
Excluding An Approximate 50 Basis Point Headwind From Foreign Exchange Based On Current Rates, We Expect Full Year 2024 Operational Revenue Growth To Be 9% To 10%, Excluding A 100 Basis Point.
Images References :
Bsx) Generated Net Sales Of $3.527 Billion During The Third Quarter Of 2023, Growing 11.2 Percent On A Reported Basis, 11.1 Percent On An Operational 1 Basis And 10.2 Percent On An Organic 2 Basis, All Compared To The Prior Year Period.
Boston scientific annual revenue for 2022 was $12.682b, a 6.68% increase from 2021.
Health Regulator Has Approved Its Heart Device.
Bsx) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a reported basis, 8.7 percent on an operational1 basis and.
Boston Scientific's Revenue In The Past Year Totalled $13.76 Billion.